New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 30, 2013
10:01 EDTSSI, RKT, PNRA, ACHN, WWAV, RP, IP, ARIA, JCP, SYT, JCI, CHRW On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARIAD (ARIA) downgraded to Market Perform from Outperform at BMO Capital... Achillion (ACHN) downgraded to Underperform from Neutral at BofA/Merrill... C.H. Robinson (CHRW) downgraded to Underperform from Sector Perform at RBC Capital... International Paper (IP) downgraded to Neutral from Buy at BofA/Merrill... Johnson Controls (JCI) downgraded to Underweight from Equal Weight at Morgan Stanley... Panera Bread (PNRA) downgraded to Equal Weight from Overweight at Morgan Stanley... RealPage (RP) downgraded to Underperform from Neutral at Credit Suisse... RockTenn (RKT) downgraded to Neutral from Buy at BofA/Merrill... Syngenta (SYT) downgraded to Neutral from Buy at Citigroup... WhiteWave Foods (WWAV) downgraded to Underperform from Market Perform at BMO Capital... Stage Stores (SSI) downgraded to Neutral from Buy at Buckingham... J.C. Penney (JCP) downgraded to Hold from Buy at Maxim.
News For ARIA;ACHN;CHRW;IP;PNRA;JCI;RP;RKT;SYT;WWAV;SSI;JCP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 24, 2015
10:01 EDTWWAVOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:22 EDTARIAOn The Fly: Pre-market Movers
Subscribe for More Information
08:41 EDTWWAVWhiteWave Foods price target raised to $50 from $40 at Oppenheimer
Subscribe for More Information
07:37 EDTARIAARIAD announces approval of Iclusig in Israel
ARIAD Pharmaceuticals and Medison Pharma announced that the Israeli Ministry of Health has granted regulatory approval for Iclusig, ponatinib, in Israel for adult patients with: Chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia who are resistant to dasatinib or nilotinib, who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate, or who have the T315I mutation Philadelphia chromosome-positive acute lymphoblastic leukaemia who are resistant to dasatinib, who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate, or who have the T315I mutation. ARIAD submitted its application for Iclusig to the Israeli Ministry of Health in June 2014. Commercial launch of Iclusig is expected to occur in Q2.
07:36 EDTWWAVWhiteWave Foods initiated with a Buy at Argus
Subscribe for More Information
March 23, 2015
11:21 EDTSYTOrigin Agritech shares spike higher after report of possible takeover interest
Subscribe for More Information
March 22, 2015
16:22 EDTSYTChina looks to develop seed program to fend off foreign competition, WSJ says
Subscribe for More Information
14:59 EDTWWAVPinnacle Foods enters bidding for meatless food company Quorn, Telegraph says
Subscribe for More Information
March 20, 2015
11:36 EDTWWAVWhiteWave Foods management to meet with Stephens
Subscribe for More Information
09:01 EDTJCPJ.C. Penney says general counsel Janet Dhillon to leave company
J.C. Penney said in a filing that effective March 20, Janet Dhillon, Executive Vice President, General Counsel and Secretary, is leaving J. C. Penney Company.
08:35 EDTRKTMeadWestvaco, RockTenn announce executive management team for combined company
Subscribe for More Information
08:34 EDTRKTMeadWestvaco, RockTenn announce executive team for combined company
MeadWestvaco (MWV) and Rock-Tenn (RKT) announced the executive leadership team for the combined company following the completion of the transaction. As previously announced, Steve Voorhees will serve as the new company’s CEO and John Luke will be non-executive chairman of the board. The executive leadership team announced today includes: Nina Butler, chief sustainability officer; Ward Dickson, chief financial officer; Pete Durette, chief strategy officer; Jennifer Graham-Johnson, chief human resources officer; Linda Schreiner, chief integration officer. The transaction remains on track to close in Q2 and is subject to shareholder approvals of both MWV and RockTenn, certain regulatory approvals and other customary closing conditions.
March 19, 2015
07:19 EDTWWAVPiper Jaffray to hold a field trip
Investor Field Trip travels throughout Boulder and Denver, Colorado on March 19.
March 18, 2015
13:30 EDTJCPJ.C. Penney trades lower after news of executive departures
Subscribe for More Information
09:25 EDTPNRAPanera Bread Q1 comps under pressure, says Cleveland Research
Cleveland Research said Neutral rated Panera Bread's Q1 comps are under pressure from weather and more difficult comparisons. The firm remains cautious on 2015 outlook given high menu pricing, competition, and a lower than expected 2.0 benefit.
March 17, 2015
15:41 EDTJCPJ.C. Penney General Counsel Janet Dhillon leaving, Bloomberg says
Subscribe for More Information
06:57 EDTJCPJ.C. Penney CMO leaves company, effective immediately, AdAge reports
Subscribe for More Information
March 16, 2015
16:02 EDTRPRealPage integrates two acquired vacation rental management platforms
RealPage announces the integration of two vacation rental management software platforms. Acquired by RealPage in early 2014, InstaManager provided booking and channel management to hundreds of vacation rental managers in the U.S. The second platform, Kigo, provided similar services to the European market. Later in 2014, RealPage acquired Kigo and has now combined the two platforms into a new, more robust solution available for license around the globe under the Kigo name.
March 15, 2015
17:43 EDTCHRWC.H. Robinson shares could rise 50%, Barron's says
Subscribe for More Information
March 13, 2015
13:27 EDTARIAARIAD drug granted orphan designation as GIST treatment
ARIAD Pharmaceuticals' Iclusig was granted FDA orphan status on February 12 as a treatment of gastrointestinal stromal tumors, or GIST, according to a post to the agency's site. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use